AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| VAR | Ann: Corporate Update - Fully Underwritten Entitlement Issue | 24/04/18 | 0 | 34 | |||
|
|||||||
| VAR | Ann: Underwritten Renounceable Rights Issue to raise $2.2M | 24/04/18 | 3 | 138 | |||
|
|||||||
| VAR | Ann: Renounceable RIghts Issue Prospectus | 24/04/18 | 0 | 41 | |||
|
|||||||
| VAR | Ann: Appendix 3b | 24/04/18 | 0 | 28 | |||
|
|||||||
| VAR | Ann: Trading Halt | 20/04/18 | 0 | 114 | |||
|
|||||||
| VAR | Ann: High Grade Copper at Rosario, Chile | 11/04/18 | 0 | 164 | |||
|
|||||||
| VAR | Ann: Board Change | 03/04/18 | 2 | 417 | |||
|
|||||||
| VAR | Ann: Appendix 3z | 29/03/18 | 0 | 48 | |||
|
|||||||
See All Discussions
ASX News